Analysis of stage and clinical/prognostic factors for lung cancer from SEER registries: AJCC staging and collaborative stage data collection system.
Analysis of stage and clinical/prognostic factors for lung cancer from SEER registries: AJCC staging and collaborative stage data collection system.
复制标题
DOI：
10.1002/cncr.29045
复制
发表时间：
2014-12-01
期刊：
影响因子：
6.2
通讯作者：
Lewis, Denise R.
中科院分区：
文献类型：
--
作者：
Chen, Vivien W.;Ruiz, Bernardo A.;Hsieh, Mei-Chin;Wu, Xiao-Cheng;Ries, Lynn A. G.;Lewis, Denise R.
美国癌症联合委员会 (AJCC) 第 7 版介绍了肺癌分期的重大变化，包括肿瘤 (T)、淋巴结 (N)、转移 (M) (TNM) 系统和新的分期/预后部位特异性因素 (SSF)，这些变化是在协作分期版本 2 (CSv2) 数据收集系统下收集的。目的是提高分期精度，从而指导治疗选择并最终提高生存率。本报告探讨了分期趋势、从 AJCC 第 6 版到第 7 版的分期分布变化以及 2010 年肺癌病例的预后 SSF 的结果。数据来自 2012 年 11 月 18 个监测、流行病学和最终结果 (SEER) 计划基于人群的登记处提交的数据。对 2004 年至 2010 年诊断的总共 344 797 例肺癌病例进行了分析。从2004年到2010年，小肿瘤和早期肺癌病例的比例有所增加。2010诊断年实施的AJCC第7版对肿瘤大小进行了细分，并对多发肿瘤结节、胸腔积液和对侧肺肿瘤的累及情况进行了重新分类，导致IB期和IIIB期略有下降，IIA期和IV期略有增加。总体而言，在 AJCC 第 6 版和第 7 版中，约 80% 的病例仍处于同一阶段组。约21%的肺癌患者在同侧（同一）肺中有单独的肿瘤结节，23%的手术切除患者有内脏胸膜侵犯，这都是不良预后因素。对于高质量的基于人群的登记（例如 SEER 计划）来说，收集更精细的分期和预后 SSF 是可行的，从而可以更好地对具有不同临床结果的肺癌患者进行分类并评估其生存率。
The American Joint Committee on Cancer (AJCC) 7th edition introduced major changes in the staging of lung cancer, including Tumor (T), Node (N), Metastasis (M) (TNM) system and new stage/prognostic site-specific factors (SSFs), collected under the Collaborative Stage Version 2 (CSv2) Data Collection System. The intent was to improve the stage precision which could guide treatment options and ultimately lead to better survival. This report examines stage trends, the change in stage distributions from the AJCC 6th to the 7th edition, and findings of the prognostic SSFs for 2010 lung cancer cases. Data were from the November 2012 submission of 18 Surveillance, Epidemiology, and End Results (SEER) Program population-based registries. A total of 344 797 cases of lung cancer, diagnosed in 2004–2010, were analyzed. The percentages of small tumors and early stage lung cancer cases increased from 2004 to 2010. The AJCC 7th edition, implemented for 2010 diagnosis year, subclassified tumor size and reclassified multiple tumor nodules, pleural effusions, and involvement of tumors in the contralateral lung, resulting in a slight decrease in stage IB and stage IIIB and a small increase in stage IIA and stage IV. Overall about 80% of cases remained the same stage group in AJCC 6th and 7th editions. About 21% of lung cancer patients had separate tumor nodules in the ipsilateral (same) lung, and 23% of the surgically resected patients had visceral pleural invasion, both adverse prognostic factors. It is feasible for high quality population-based registries such as the SEER Program to collect more refined staging and prognostic SSFs that allows better categorization of lung cancer patients with different clinical outcomes and to assess their survival.
登录
查看更多内容
DOI：
10.1016/j.jtcvs.2012.05.060
发表时间：
2012-07-01
影响因子：
6
作者：
Jaklitsch, Michael T.;Jacobson, Francine L.;Sugarbaker, David J.
通讯作者：
Sugarbaker, David J.
影响因子：
254.7
作者：
Siegel, Rebecca;Ma, Jiemin;Jemal, Ahmedin
通讯作者：
Jemal, Ahmedin
影响因子：
10
作者：
Strand, T-E;Rostad, H.;Norstein, J.
通讯作者：
Norstein, J.
影响因子：
39.2
作者：
Moyer, Virginia A.
通讯作者：
Moyer, Virginia A.
影响因子：
20.4
作者：
Goldstraw, Peter;Crowley, John;Sobin, Leslie
通讯作者：
Sobin, Leslie